CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Registration Number
- NCT05652569
- Lead Sponsor
- German Cancer Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria:<br><br> - Female and male breast cancer patients = 18 or if the legal guardian has agreed to<br> the respective informed consent form (ICF)<br><br> - Patients with advanced or metastatic breast cancer (irrespective of clinical<br> parameters such as TNM, subgroups, therapy lines)<br><br> - Patients, who agreed to and were able to sign the informed consent form.<br><br>Exclusion Criteria:<br><br> - Early breast cancer<br><br> - Inability to take a tissue bioptic sample due to reasons such as physical location<br> of the lesion or health of the patient<br><br> - Any physical or mental handicap or severe comorbidities that would hamper the<br> adequate cooperation with the patient.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Setup of the molecular profiling diagnostic platform and feasibility of genomic profiling in metastatic breast cancer.;Total number of patients eligible for clinical trials and targeted therapies based on clinical characteristics and comprehensive tumor features.
- Secondary Outcome Measures
Name Time Method Secondary outcome measures Building novel therapeutic hypothesis.